Department of Pharmacy, Kobe University Hospital, Kobe, Japan.
Geriatr Gerontol Int. 2019 Nov;19(11):1101-1107. doi: 10.1111/ggi.13773.
This study aimed to evaluate the efficacy of pharmacists' assessment and intervention using the Screening Tool for Older Persons' Appropriate Prescriptions for Japanese (STOPP-J) to detect and correct potentially inappropriate medications (PIM) compared with the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) criteria version 2.
A prospective observational study was carried out at a medical unit of Cardiovascular Surgery and Cardiovascular Internal Medicine in a Japanese university hospital involving new inpatients aged ≥65 years prescribed one or more daily medication. Pharmacists detected PIM based on STOPP-J and STOPP criteria version 2, and corrected them with physicians. The number of patients with PIM, the content and changes in PIM were compared between both criteria.
Overall, 230 patients were included (mean age 75.4 years, 162 men, mean number of medications 8.3). STOPP-J detected significantly more patients with PIM than STOPP criteria version 2 (122 [53%] vs 75 [33%], P < 0.001). The number of PIM based on STOPP-J was 232, the physicians were recommended to change 61 (26%) and 50 (22%) were changed. Meanwhile, the number of PIM based on STOPP criteria version 2 was 133, the physicians were recommended to change 61 (46%) and 54 (41%) were changed. Several medications detected as PIM using STOPP-J were not detected using STOPP criteria version 2.
STOPP-J detected significantly more patients with PIM than STOPP criteria version 2, and pharmacists' assessment and intervention based on STOPP-J were suggested to be effective for detecting and correcting PIM. Geriatr Gerontol Int 2019; 19: 1101-1107.
本研究旨在评估药师使用老年人适宜处方筛查工具-日本版(STOPP-J)评估和干预以发现和纠正潜在不适当药物(PIM)的效果,与老年人潜在不适当处方筛查工具(STOPP)标准第 2 版进行比较。
在日本一所大学医院的心血管外科和心血管内科进行了一项前瞻性观察性研究,涉及新入院的≥65 岁且每天服用一种或多种药物的患者。药师根据 STOPP-J 和 STOPP 标准第 2 版发现 PIM,并与医生一起纠正。比较了两种标准的患者 PIM 数量、PIM 的内容和变化。
共纳入 230 例患者(平均年龄 75.4 岁,162 名男性,平均用药数 8.3 种)。STOPP-J 检测到的 PIM 患者明显多于 STOPP 标准第 2 版(122[53%]vs 75[33%],P<0.001)。基于 STOPP-J 的 PIM 数量为 232,医生建议更改 61(26%),其中 50(22%)被更改。同时,基于 STOPP 标准第 2 版的 PIM 数量为 133,医生建议更改 61(46%),其中 54(41%)被更改。一些基于 STOPP-J 检测到的 PIM 药物未基于 STOPP 标准第 2 版检测到。
STOPP-J 检测到的 PIM 患者明显多于 STOPP 标准第 2 版,基于 STOPP-J 的药师评估和干预措施对于发现和纠正 PIM 是有效的。